[PR Newswire] - INCLINE VILLAGE, Nev., March 4, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the:2.875% Convertible Senior Notes due February 15, ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment